Alpha Tau Medical (DRTS) Accounts Payables (2020 - 2026)

Alpha Tau Medical has reported Accounts Payables for 7 years, with the latest figure at $3.7 million in Q1 2026.

• Quarterly Accounts Payables rose 44.28% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 44.28% YoY) and the FY2025 annual result came in at $3.9 million, up 9.54% from the prior year.
• Accounts Payables declined to $3.7 million in Q1 2026 per DRTS's latest filing, from $3.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $3.9 million in Q4 2025 and troughed at $1.2 million in Q2 2022.
• A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Accounts Payables.
• The widest YoY moves for Accounts Payables: up 80.32% in 2023, down 45.99% in 2023.
• Over 5 years, Accounts Payables stood at $1.4 million in 2022, then jumped by 80.32% to $2.6 million in 2023, then jumped by 37.61% to $3.5 million in 2024, then climbed by 9.54% to $3.9 million in 2025, then dropped by 3.88% to $3.7 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.7 million, $3.9 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.